Pharmacy Medical News about Chemotherapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen
Drugs & Therapy Perspectives, 09/10/09

Chemotherapy–induced nausea and vomiting is a common, under–recognized condition that frequently requires preventive treatment. Preventive treatment involves specific single– or multi–drug regimens targeted according to patient risk and emetogenic potential of the planned chemotherapy regimen.

<< Previous
UK Pharmacies Dealing with Drug Shortages

Next >>
Local anaesthetic drugs: adverse effects as reported through the...

A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09 Relevance Score: 92%

Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients
Evidence-based Complementary and Alternative Medicine, 11/20/09 Relevance Score: 91%

Selective internal radiation therapy for liver metastases from colorectal cancer
Cochrane Reviews, 10/09/09 Relevance Score: 91%

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
The Lancet Oncology - Online First, 10/30/09 Relevance Score: 90%

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09 Relevance Score: 90%